Teva To Axe Around 350 Jobs At Israeli API Site
Falls Under Company’s 'Optimization Program'
Executive Summary
Teva CEO Kåre Schultz made fast, dramatic changes when he arrived at the generic drug giant back in 2017. With Schultz’s two-year restructuring initiative reaching its conclusion earlier this year, Teva is now kicking on with a ‘global optimization program’ geared towards making its sites “efficient and sustainable.”